期刊文献+

Research progress of peroxisome proliferator-activated receptor α in metabolic diseases

下载PDF
导出
摘要 Peroxisome proliferator-activated receptorα(PPAR-α)is a transcription factor activated by ligand receptors and is a subfamily of the nuclear receptor superfamily.The PPAR subfamily consists of three subtypes:PPAR-α(NR1C1),PPAR-β/δ(NR1C2)and PPAR-γ(NR1C3).Among them,PPAR-αis the first discovered transcription factor and the main regulator of fatty acid oxidation homeostasis.Some natural and synthetic ligands can activate PPAR-α,and the activation of PPAR-αthrough its ligands can modify many of the cells in the cell.Biological processes,these processes are closely related to the energy metabolism mechanism of metabolic diseases,so it represents an important molecular target for the development of new drugs for the treatment of metabolic diseases.The following summarizes the latest progress of PPAR-αand energy metabolism in terms of the structure and distribution of PPAR-α,its role in different tissues,and its role in metabolic diseases,etc.,providing a theoretical basis for the prevention and treatment of metabolic diseases.
机构地区 College of Pharmacy
出处 《Journal of Hainan Medical University》 2021年第22期58-64,共7页 海南医学院学报(英文版)
基金 Graduate Innovation Project of Shaanxi University of Traditional Chinese Medicine(No.2020CX06) National Natural Science Foundation of China(No.81303243) Project of Shaanxi Provincial Department of Education(No.20JC012) Research and Innovation Team of Traditional Chinese Medicine Properties and Compatibility Mechanism Based on"Properties-effect"Correlation Characteristics(No.2019-QN02)。
  • 相关文献

参考文献8

二级参考文献32

共引文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部